Zobrazeno 1 - 2
of 2
pro vyhledávání: '"JF Egido Arroyo"'
Acute cardiovascular events in type 2 diabetics treated with SGLT2i. Results of a real life registry
Autor:
B Maiz Alcorta, L Quintas Ovejero, I Larranaga Unanue, A Aspiazu Abasolo, R Agirrezabalaga Villar, N Rico Dadebat, AC Armentia Del Pozo, S Diez Irizar, JF Egido Arroyo, L Manas Alonso, A Moreno Rodrigo, C Goena Vives, N Andres Imaz, T Arana Suarez, I Larranaga Gomez
Publikováno v:
Eur Heart J Acute Cardiovasc Care
Funding Acknowledgements Type of funding sources: None. Introduction and objectives Sodium-glucose co-transporter type 2 inhibitors (SGLT2i) have proven to reduce risk of cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM). The a
Publikováno v:
Atencion primaria [Aten Primaria] 2005 Jun 30; Vol. 36 (2), pp. 112.